BACKGROUND: Infliximab has been shown to be of benefit in the treatment of ulcerative colitis but long-term colectomy rates remain unknown. AIMS: To review the rate of colectomy after infliximab for ulcerative colitis and to identify factors that might predict the need for colectomy. METHODS: We conducted a retrospective cohort study of patients with active ulcerative colitis treated with infliximab between 2000 and 2006. The primary outcome was colectomy-free survival. Disease and treatment ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record